Navigation Links
Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
Date:1/31/2013

AUSTIN, Texas, Jan. 31, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Leerink Swann Global Healthcare Conference to be held February 13 -14, 2013, in New York, NY.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

The investor presentation by Patrick J. Balthrop , president and chief executive officer, will begin at 11:30 a.m. Eastern time on Thursday, February 14, 2013.  The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

ABOUT LUMINEX CORPORATION Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic,
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Luminex Corporation Reports Third Quarter 2012 Results
2. Luminex Corporation To Present At Upcoming Investment Conferences In September
3. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
4. Luminex Corporation Recognized as Best Technology Company in Austin
5. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
6. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
7. Luminex Corporation Reports Second Quarter 2012 Results
8. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
9. Luminex Corporation Announces Agreement to Acquire GenturaDx
10. Luminex Corporation Reports First Quarter 2012 Results
11. NewLink Genetics Corporation Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  Omeros Corporation (NASDAQ: OMER ) ... (IND) to evaluate OMS824 in Huntington,s disease has ... Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), ... linked to a wide range of diseases that ... has shown promising results in animal models directly ...
(Date:5/23/2013)... ATLANTA , May 23, 2013  Inhibikase ... treatments, announced today that it will present new ... at an industry conference sponsored by the PML ... Biogen Idec).  JC polyomavirus (JCV) is the causative ... host-directed tyrosine kinase inhibitor in an extended release ...
(Date:5/23/2013)... , May 23, 2013 ... MKT: NSPR), the leader in embolic protection stents, ... (MGuard for Acute ST Elevation Reperfusion) trial demonstrating ... bare metal and drug eluting stents in all-cause ... patients.  Results from the trial were presented at ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
(Date:5/23/2013)... San Francisco, CA (PRWEB) May 23, 2013 ... community safety outreach program being tackled by the Safe ... its second Fullpower personal safety workshop for ... develops and teaches personal safety skills programs for people ... been telling us their experiences with street harassment for ...
(Date:5/23/2013)... Lake City, Utah (PRWEB) May 23, 2013 ... Chevreau, PhD, R.D., published an article today on Tatalou.com ... an illness-free vacation. , The article, titled “ How ... why it’s important to carry hand sanitizer, when it’s ... to watch out for seafood, the importance of staying ...
(Date:5/23/2013)... 23, 2013 Dimensional Insight, a ... announced today that Paul Comras, director of ... at the 2013 International Medical Users Software Exchange ... & Revenue Visibility from Your General Ledger.” The ... from 2:30-3:25 p.m. in Azalea 1 at the ...
(Date:5/23/2013)... Alexandria, VA (PRWEB) May 23, 2013 Memorial ... start of the summer season for many Americans. Across the ... the long weekend. NHPCO encourages Americans to reach out to ... in military service. , As the nation marks Memorial Day ... Serious injuries and the untimely deaths of brave service men ...
(Date:5/23/2013)... To better serve the architecture ... pleased to announce the release of its new ... space division products. Provided by Koroseal, a leader ... patterns and colors represent a sophisticated response to ... a team of Koroseal experts, Modernfold reviewed hundreds ...
Breaking Medicine News(10 mins):Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 2Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 3Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 4Health News:How to Stay Healthy While Traveling 2Health News:Dimensional Insight to Demonstrate How Hospitals Can Use Business Intelligence within MEDITECH Environments at 2013 International MUSE Conference 2Health News:Memorial Day: Make it a Time of Remembrance and Support 2Health News:Memorial Day: Make it a Time of Remembrance and Support 3Health News:Modernfold Debuts New Colors and Patterns for Space Division Products 2
... treatment if they donate eggs for controversial cloning research.// ... for ‘egg sharing' so as to advance work on human ... this scheme and pass on their spare eggs to the ... by almost half. , ,The researcher team from ...
... of Agriculture have indicated the enhanced nutritive benefits of ... ,According to scientists, watermelons are a production ... the parent plant, which slows down once the melon ... 70 degrees, contained almost 40% of lycopene and 50 ...
... than with most modern antibiotics, according to a recent ... from the University of Bonn, Germany in collaboration with ... that medihoney is a very effective treatment for several ... infected with multi-resistant bacteria within a few weeks. ...
... and Channel 7 Indian Television network has raised many questions ... professionals. A cleaning up operation is long overdue to rejuvenate ... World Medical Association in 1949 - I ... of humanity …. I will practice my profession with conscience ...
... to an article that was published in the July 24 ... the JAMA/Archives journals, states that women who take// combination of ... have an increased risk of breast cancer. ... their normal levels of the testosterone hormone would be likely ...
... drug that is widely used in heart failure. Some ... is contraindicated. //However a new analysis shows that the ... heart failure. ,"Contrary to conventional wisdom, digitalis ... advances our understanding of both digitalis, the oldest known ...
Cached Medicine News:Health News:IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme 2Health News:IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme 3Health News:Maimed Conscience and Maimed Beggars (Medical Ethics in India) – Part 2Health News:Maimed Conscience and Maimed Beggars (Medical Ethics in India) – Part 3Health News:Maimed Conscience and Maimed Beggars (Medical Ethics in India) – Part 4Health News:Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy 2Health News:Digitalis Could Be Safe In Diastolic Heart Failure 2Health News:Digitalis Could Be Safe In Diastolic Heart Failure 3
Very compressive support for submental liposuction...
Applies pressure on scalp to stretch it before surgery...
Deluxe Abdominal Binders...
Ideal for abdominal, flank, hip and thigh procedures....
Medicine Products: